Skip to main content
Top
Published in: Annals of Surgical Oncology 1/2021

01-01-2021 | Gastrectomy | Health Services Research and Global Oncology

Longitudinal Analysis of Quality-of-Life Recovery After Gastrectomy for Cancer

Authors: Yinin Hu, MD, Elvira L. Vos, MD, Raymond E. Baser, MS, Mark A. Schattner, MD, Makoto Nishimura, MD, Daniel G. Coit, MD, Vivian E. Strong, MD

Published in: Annals of Surgical Oncology | Issue 1/2021

Login to get access

Abstract

Objective

The purpose of this study was to identify factors associated with quality-of-life recovery after gastrectomy.

Methods

Patients anticipated to undergo gastric cancer resection were invited to complete the European Organisation for Research and Treatment of Cancer (EORTC) QLQ C30 and STO22 surveys in the preoperative setting and at 0–1.5 months (early), > 1.5–6 months (intermediate), and > 6–18 months (late) following resection. Quality-of-life recovery was measured as paired differences between pre- and postoperative results. Multivariable linear regression identified factors associated with preoperative quality of life and degree of change following resection.

Results

Across 393 participants, response rates at the intermediate and late postoperative time points were 58% (n = 228) and 71% (n = 277), respectively. Relative to baseline, median global health scale decreased in the early (− 15.1 pts, p < 0.001) and intermediate (− 3.6 pts, p = 0.02) time points, but recovered by the late time point (+ 1.2 pts, p = 0.411). Relative to distal/subtotal gastrectomy, proximal/total gastrectomy was associated with worse recovery in both the early and late time points. Surgical complications were associated with worse early recovery. Patients who presented with locally advanced tumors (T3–T4) had lower preoperative quality-of-life scores, and more readily recovered to baseline after surgery. A minimally invasive approach was not associated with postoperative recovery.

Conclusions

Most patients recover to baseline within 1 year following major gastrectomy, and recovery is easier with more limited resections. Patients with locally advanced tumors tend to have poorer baseline quality of life, which may improve following resection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRef Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRef
2.
go back to reference Jabo B, Selleck MJ, Morgan JW, et al. Comparison of perioperative chemotherapy with adjuvant chemoradiotherapy for resectable gastric cancer: findings from a population-based study. J Gastrointest Oncol. 2018;9(1):35–45.CrossRef Jabo B, Selleck MJ, Morgan JW, et al. Comparison of perioperative chemotherapy with adjuvant chemoradiotherapy for resectable gastric cancer: findings from a population-based study. J Gastrointest Oncol. 2018;9(1):35–45.CrossRef
3.
go back to reference Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995;345(8952):745–8.CrossRef Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995;345(8952):745–8.CrossRef
4.
go back to reference Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The surgical cooperative group. Lancet. 1996;347(9007):995–9.CrossRef Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The surgical cooperative group. Lancet. 1996;347(9007):995–9.CrossRef
5.
go back to reference Gosselin-Tardif A, Lie J, Nicolau I, et al. Gastrectomy with extended lymphadenectomy: a North American perspective. J Gastrointest Surg. 2018;22(3):414–20.CrossRef Gosselin-Tardif A, Lie J, Nicolau I, et al. Gastrectomy with extended lymphadenectomy: a North American perspective. J Gastrointest Surg. 2018;22(3):414–20.CrossRef
6.
go back to reference Randle RW, Swords DS, Levine EA, et al. Optimal extent of lymphadenectomy for gastric adenocarcinoma: a 7-institution study of the U.S. gastric cancer collaborative. J Surg Oncol. 2016;113(7):750–5.CrossRef Randle RW, Swords DS, Levine EA, et al. Optimal extent of lymphadenectomy for gastric adenocarcinoma: a 7-institution study of the U.S. gastric cancer collaborative. J Surg Oncol. 2016;113(7):750–5.CrossRef
7.
go back to reference Nakada K, Ikeda M, Takahashi M, et al. Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients. Gastric Cancer. 2015;18(1):147–58.CrossRef Nakada K, Ikeda M, Takahashi M, et al. Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients. Gastric Cancer. 2015;18(1):147–58.CrossRef
8.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, et al. The european organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.CrossRef Aaronson NK, Ahmedzai S, Bergman B, et al. The european organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.CrossRef
9.
go back to reference Vickery CW, Blazeby JM, Conroy T, et al. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer. Eur J Cancer. 2001;37(8):966–71.CrossRef Vickery CW, Blazeby JM, Conroy T, et al. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer. Eur J Cancer. 2001;37(8):966–71.CrossRef
10.
go back to reference Huang CC, Lien HH, Wang PC, Yang JC, Cheng CY, Huang CS. Quality of life in disease-free gastric adenocarcinoma survivors: Impacts of clinical stages and reconstructive surgical procedures. Dig Surg. 2007;24(1):59–65.CrossRef Huang CC, Lien HH, Wang PC, Yang JC, Cheng CY, Huang CS. Quality of life in disease-free gastric adenocarcinoma survivors: Impacts of clinical stages and reconstructive surgical procedures. Dig Surg. 2007;24(1):59–65.CrossRef
11.
go back to reference Rausei S, Mangano A, Galli F, et al. Quality of life after gastrectomy for cancer evaluated via the EORTC QLQ-C30 and QLQ-STO22 questionnaires: surgical considerations from the analysis of 103 patients. Int J Surg. 2013;11(Suppl 1):S104–9.CrossRef Rausei S, Mangano A, Galli F, et al. Quality of life after gastrectomy for cancer evaluated via the EORTC QLQ-C30 and QLQ-STO22 questionnaires: surgical considerations from the analysis of 103 patients. Int J Surg. 2013;11(Suppl 1):S104–9.CrossRef
12.
go back to reference Lee SS, Chung HY, Kwon OK, Yu W. Long-term quality of life after distal subtotal and total gastrectomy: symptom- and behavior-oriented consequences. Ann Surg. 2016;263(4):738–44.CrossRef Lee SS, Chung HY, Kwon OK, Yu W. Long-term quality of life after distal subtotal and total gastrectomy: symptom- and behavior-oriented consequences. Ann Surg. 2016;263(4):738–44.CrossRef
13.
go back to reference Lee MS, Ahn SH, Lee JH, et al. What is the best reconstruction method after distal gastrectomy for gastric cancer? Surg Endosc. 2012;26(6):1539–47.CrossRef Lee MS, Ahn SH, Lee JH, et al. What is the best reconstruction method after distal gastrectomy for gastric cancer? Surg Endosc. 2012;26(6):1539–47.CrossRef
14.
go back to reference Brenkman HJF, Tegels JJW, Ruurda JP, et al. Factors influencing health-related quality of life after gastrectomy for cancer. Gastric Cancer. 2018;21(3):524–32.CrossRef Brenkman HJF, Tegels JJW, Ruurda JP, et al. Factors influencing health-related quality of life after gastrectomy for cancer. Gastric Cancer. 2018;21(3):524–32.CrossRef
15.
go back to reference Fein M, Fuchs KH, Thalheimer A, Freys SM, Heimbucher J, Thiede A. Long-term benefits of roux-en-Y pouch reconstruction after total gastrectomy: a randomized trial. Ann Surg. 2008;247(5):759–65.CrossRef Fein M, Fuchs KH, Thalheimer A, Freys SM, Heimbucher J, Thiede A. Long-term benefits of roux-en-Y pouch reconstruction after total gastrectomy: a randomized trial. Ann Surg. 2008;247(5):759–65.CrossRef
16.
go back to reference Lee SS, Ryu SW, Kim IH, Sohn SS. Quality of life beyond the early postoperative period after laparoscopy-assisted distal gastrectomy: the level of patient expectation as the essence of quality of life. Gastric Cancer. 2012;15(3):299–304.CrossRef Lee SS, Ryu SW, Kim IH, Sohn SS. Quality of life beyond the early postoperative period after laparoscopy-assisted distal gastrectomy: the level of patient expectation as the essence of quality of life. Gastric Cancer. 2012;15(3):299–304.CrossRef
17.
go back to reference Karanicolas PJ, Graham D, Gonen M, Strong VE, Brennan MF, Coit DG. Quality of life after gastrectomy for adenocarcinoma: a prospective cohort study. Ann Surg. 2013;257(6):1039–46.CrossRef Karanicolas PJ, Graham D, Gonen M, Strong VE, Brennan MF, Coit DG. Quality of life after gastrectomy for adenocarcinoma: a prospective cohort study. Ann Surg. 2013;257(6):1039–46.CrossRef
18.
go back to reference Jentschura D, Winkler M, Strohmeier N, Rumstadt B, Hagmuller E. Quality-of-life after curative surgery for gastric cancer: a comparison between total gastrectomy and subtotal gastric resection. Hepatogastroenterology. 1997;44(16):1137–42.PubMed Jentschura D, Winkler M, Strohmeier N, Rumstadt B, Hagmuller E. Quality-of-life after curative surgery for gastric cancer: a comparison between total gastrectomy and subtotal gastric resection. Hepatogastroenterology. 1997;44(16):1137–42.PubMed
19.
go back to reference Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582–92.PubMed Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582–92.PubMed
20.
go back to reference R Core Team. R: A language and environment for statistical computing. The R Core Team; 2020. R Core Team. R: A language and environment for statistical computing. The R Core Team; 2020.
21.
go back to reference Kim AR, Cho J, Hsu YJ, et al. Changes of quality of life in gastric cancer patients after curative resection: a longitudinal cohort study in Korea. Ann Surg. 2012;256(6):1008–13.CrossRef Kim AR, Cho J, Hsu YJ, et al. Changes of quality of life in gastric cancer patients after curative resection: a longitudinal cohort study in Korea. Ann Surg. 2012;256(6):1008–13.CrossRef
22.
go back to reference Gamper EM, Holzner B, King MT, et al. Test-retest reliability of discrete choice experiment for valuations of QLU-C10D health states. Value Health. 2018;21(8):958–66.CrossRef Gamper EM, Holzner B, King MT, et al. Test-retest reliability of discrete choice experiment for valuations of QLU-C10D health states. Value Health. 2018;21(8):958–66.CrossRef
23.
go back to reference Rowen D, Brazier J, Young T, et al. Deriving a preference-based measure for cancer using the EORTC QLQ-C30. Value Health. 2011;14(5):721–31.CrossRef Rowen D, Brazier J, Young T, et al. Deriving a preference-based measure for cancer using the EORTC QLQ-C30. Value Health. 2011;14(5):721–31.CrossRef
24.
go back to reference Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg. 1999;230(2):170–8.CrossRef Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg. 1999;230(2):170–8.CrossRef
25.
go back to reference Robertson CS, Chung SC, Woods SD, et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg. 1994;220(2):176–82.CrossRef Robertson CS, Chung SC, Woods SD, et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg. 1994;220(2):176–82.CrossRef
26.
go back to reference Nakada K, Takahashi M, Ikeda M, et al. Factors affecting the quality of life of patients after gastrectomy as assessed using the newly developed PGSAS-45 scale: a nationwide multi-institutional study. World J Gastroenterol. 2016;22(40):8978–90.CrossRef Nakada K, Takahashi M, Ikeda M, et al. Factors affecting the quality of life of patients after gastrectomy as assessed using the newly developed PGSAS-45 scale: a nationwide multi-institutional study. World J Gastroenterol. 2016;22(40):8978–90.CrossRef
27.
go back to reference Park S, Chung HY, Lee SS, Kwon O, Yu W. Serial comparisons of quality of life after distal subtotal or total gastrectomy: what are the rational approaches for quality of life management? J Gastric Cancer. 2014;14(1):32–8.CrossRef Park S, Chung HY, Lee SS, Kwon O, Yu W. Serial comparisons of quality of life after distal subtotal or total gastrectomy: what are the rational approaches for quality of life management? J Gastric Cancer. 2014;14(1):32–8.CrossRef
28.
go back to reference Tey J, Zheng H, Soon YY, et al. Palliative radiotherapy in symptomatic locally advanced gastric cancer: a phase II trial. Cancer Med. 2019;8(4):1447–58.CrossRef Tey J, Zheng H, Soon YY, et al. Palliative radiotherapy in symptomatic locally advanced gastric cancer: a phase II trial. Cancer Med. 2019;8(4):1447–58.CrossRef
29.
go back to reference Xu J, Evans TJ, Coon C, Copley-Merriman K, Su Y. Measuring patient-reported outcomes in advanced gastric cancer. Ecancermedicalscience. 2013;7:351.PubMedPubMedCentral Xu J, Evans TJ, Coon C, Copley-Merriman K, Su Y. Measuring patient-reported outcomes in advanced gastric cancer. Ecancermedicalscience. 2013;7:351.PubMedPubMedCentral
30.
go back to reference Suk H, Kwon OK, Yu W. Preoperative quality of life in patients with gastric cancer. J Gastric Cancer. 2015;15(2):121–6.CrossRef Suk H, Kwon OK, Yu W. Preoperative quality of life in patients with gastric cancer. J Gastric Cancer. 2015;15(2):121–6.CrossRef
31.
go back to reference Kim YW, Baik YH, Yun YH, et al. Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg. 2008;248(5):721–7.CrossRef Kim YW, Baik YH, Yun YH, et al. Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg. 2008;248(5):721–7.CrossRef
32.
go back to reference Kim YW, Yoon HM, Yun YH, et al. Long-term outcomes of laparoscopy-assisted distal gastrectomy for early gastric cancer: result of a randomized controlled trial (COACT 0301). Surg Endosc. 2013;27(11):4267–76.CrossRef Kim YW, Yoon HM, Yun YH, et al. Long-term outcomes of laparoscopy-assisted distal gastrectomy for early gastric cancer: result of a randomized controlled trial (COACT 0301). Surg Endosc. 2013;27(11):4267–76.CrossRef
33.
go back to reference Haverkamp L, Brenkman HJ, Seesing MF, et al. Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial). BMC Cancer. 2015;15:556.CrossRef Haverkamp L, Brenkman HJ, Seesing MF, et al. Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial). BMC Cancer. 2015;15:556.CrossRef
Metadata
Title
Longitudinal Analysis of Quality-of-Life Recovery After Gastrectomy for Cancer
Authors
Yinin Hu, MD
Elvira L. Vos, MD
Raymond E. Baser, MS
Mark A. Schattner, MD
Makoto Nishimura, MD
Daniel G. Coit, MD
Vivian E. Strong, MD
Publication date
01-01-2021
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 1/2021
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-09274-z

Other articles of this Issue 1/2021

Annals of Surgical Oncology 1/2021 Go to the issue